FEATURED EPISODE
Expanding access to cell and gene therapies with McKesson’s Joe DePinto
Joe DePinto, McKesson’s head of cell and gene advanced therapies, is passionate about helping patients get access to these groundbreaking therapeutic interventions. Maria Whitman gets Joe’s perspective on the current state of cell and gene therapy.
Featured episode
Advancing pharma research for everyone: The clinical site perspective
Clinical trial sites play an important role in biopharma’s success. On this episode of Transforming Biopharma, Maria Whitman talks with Lauren Wall of the University of Chicago and Caroline Smith of Charter Research, on how pharma can forge successful partnerships with sites. They identify factors such as patient-centric trial design and the importance of understanding site challenges to improve the clinical trial process.
FEATURED EPISODE
Future focus: How the AHA is tackling cardiac health and more with Juliana Crawford
If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American Heart Association (AHA) is pursuing that vision. Maria Whitman talks with Juliana Crawford, EVP of emerging strategies at the AHA, to find out how the association is thinking about how policy, science and consumer education can fit together in a broad approach to solving healthcare problems.
FEATURED EPISODE
Beyond process improvement: Why organizational architecture matters with Mike Tushman
Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He describes how companies that successfully transform create an organizational architecture that allows both “exploitation” of existing successful strategies and “exploration” of what they might build for the future. He also discusses the role of leaders in driving transformation and the potential of generative AI.
Featured episode
Navigating the system, meeting patients where they are with Oya Gilbert
How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple myeloma patient. They also talk about Oya’s work with the Health, Hope and Hip-Hop Foundation, which aims to use hip-hop culture to promote health literacy in underserved communities.
Featured episode
From data collection to data connection: Reinventing pharma’s commercial model
How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial model.
Featured episode
Resetting how we think about obesity: A patient’s point of view
Bill Coyle, ZS’s global head of biopharma, and Mandi White-Ajmani, Ph.D., clinical psychologist, join Maria Whitman to talk about the underlying challenges obesity presents to society and healthcare even as new treatments emerge. Dr. White-Ajmani shares her weight loss journey and reflects on how it has affected her life.
- A
- b
- c
- D
- E
- F
- G
Miniseries
- Future of Commercial Model
- Future of Health
- Precision Medicine
Pharma's commercial model of tomorrow starts today
Building connections to reimagine healthcare
How biopharma can mobilize to design, develop and deliver precision medicine
About the Host
Maria Whitman is ZS’s managing partner, global commercialization strategy and solutions. A longtime leader in life sciences, she is dedicated to advancing health. She advises on strategy for top pharmaceutical and biotech companies to drive performance and engagement in the ecosystem to improve patient outcomes.